These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12843008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A, Heim K, Guger M, Ciresa-Kö Nig A, Christensen N, Sarcletti M, Wieland U, Pfister H, Zangerle R, Höpfl R.
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
    Hernandez BY, Ton T, Shvetsov YB, Goodman MT, Zhu X.
    Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294
    [Abstract] [Full Text] [Related]

  • 9. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions.
    Sasagawa T, Yamazaki H, Dong YZ, Satake S, Tateno M, Inoue M.
    Int J Cancer; 1998 Feb 09; 75(4):529-35. PubMed ID: 9466652
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CM, Williamson AL.
    J Med Virol; 2000 Apr 09; 60(4):403-10. PubMed ID: 10686023
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
    Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group.
    Sex Transm Dis; 2011 Oct 09; 38(10):976-82. PubMed ID: 21934576
    [Abstract] [Full Text] [Related]

  • 13. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T, Inoue M, Lehtinen M, Zhang W, Gschmeissner SE, Hajibagheri MA, Finch J, Crawford L.
    Clin Diagn Lab Immunol; 1996 Jul 09; 3(4):403-10. PubMed ID: 8807204
    [Abstract] [Full Text] [Related]

  • 14. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP, Ahdieh-Grant L, Schneider MF, Clayman B, Massad LS, Anastos KM, Burk RD, Minkoff H, Palefsky J, Levine A, Strickler H.
    J Infect Dis; 2003 Dec 15; 188(12):1834-44. PubMed ID: 14673762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
    Fei M, Li J, Du J, You J, Zhang S, He W, Kang L, Zhao F, Qiao Y, Si Y, Fan X, Chen W.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May 15; 35(5):514-8. PubMed ID: 25059358
    [Abstract] [Full Text] [Related]

  • 20. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.
    Balmelli C, Roden R, Potts A, Schiller J, De Grandi P, Nardelli-Haefliger D.
    J Virol; 1998 Oct 15; 72(10):8220-9. PubMed ID: 9733865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.